2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole

Star0

DB07014ExperimentalSmall molecule

2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole: Overview.

Formula / weight: C₁₇H₁₃FN₂O₄S · 360.36 g/mol (avg)

Resolves to

Compound

UNIICG29TW6UG8ChEMBLCHEMBL456218PubChem2079916

Structure

InChIKeyTUTZKAQTSPMEBI-UHFFFAOYSA-NSMILESCOC1=C(F)C=C(CSC2=NN=C(O2)C2=CC3=C(OCO3)C=C2)C=C1

Targets

P49841GSK3B

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account